Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

NCT03391973 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma of Unknown Primary

Interventions

DRUG: Pembrolizumab Injection

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]